Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Endophthalmitis after Intravitreal Injection of Triamcinolone Acetonide

Kamppeter B. A., Jonas J. B., Kreissig I., Degenring R. F.
Dept. of Ophthalmology, Faculty for Clinical Medicine Mannheim, University Heidelberg

Purpose: To report the rate of infectious endophthalmitis and post-injection sterile intraocular inflammation after intravitreal injections of triamcinolone acetonide. Design. Interventional case series study.
Method: The study included 327 eyes which consecutively received intravitreal single or repeated injections of 25 mg of triamcinolone acetonide for treatment of edematous, neovascular, proliferative, or inflammatory ocular diseases. With topical anesthesia, the injection was performed in sterile conditions in the operation theater. The solvent agent was removed prior to the injection. Mean follow-up was 5.1 ± 4.7 months (range, one week – 23.8 months).
Results: In none of the patients, an injection-related infectious endophthalmitis or a sterile post-injection intraocular inflammation was detected.
Conclusions: If the procedure is performed under sterile conditions in the operation theater, and if the solvent agent is removed, a post-injection endophthalmitis or post-injection intraocular inflammation may only rarely occur.


Zurück | Back